
Please try another search
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Name | Age | Since | Title |
---|---|---|---|
Roger Campbell Corbett | 78 | 2010 | Independent Chairman |
Bruce Lawrence Mathieson | 78 | 2007 | Independent Non Executive Director |
Frank Charles Condella | 67 | 2018 | Independent Non-Executive Chairman |
Shawn Patrick O’Brien | - | 2022 | CEO, MD & Director |
Bruce G. Robinson | 65 | 2014 | Independent Non-Executive Director |
Patrick J. Blake | 58 | 2018 | Independent Non-Executive Director |
Ann Custin | 62 | 2022 | Independent Non-Executive Director |
Kathryn MacFarlane | 57 | 2022 | Independent Non-Executive Director |
David Petrie | 58 | 2022 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review